Ataxia-telangiectasia gene
US6211336A · kind A · utility
2Cited by
12References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 26, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Feb 26, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a purified amino acid sequence selected from the group of Sequence ID No.: 3 and analogs thereof and mutations of Sequence ID No.: 3 which cause ataxia-telangiectasia. Also provided is a purified amino acid sequence as set forth in Sequence ID No.: 3 and analogs thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.